Artificial Intelligence in Prostate Cancer: from clinic to lab 

We are delighted to welcome our guest speakers; Pr. Sophie Ferlicot, Head of the Department of Pathology of Bicêtre Hospital, AP-HP, Paris-Saclay University, and Dr. Mario Terlizzi, a radiation oncologist and brachytherapist at the Gustave Roussy Institute for our sixth episode of the 'Better Testing, Better Treatment' podcast series. 

Prof. Sopie Ferlicot and Dr. Mario Terlizzi explore the applications of AI in prostate cancer care, including diagnostics (imaging and histological assessment), and therapeutics. 

Don't forget to catch up on previous episodes!

Listen now

We are excited to announce that our sixth episode is available now.

Oncogenic Fusion detection and reporting in NSCLC and solid tumors: from clinic to lab

Episode 5 in the ‘Better Testing, Better Treatment’ podcast series, focuses on the practical considerations for oncogenic fusion detection and reporting. In this podcast, our guests discuss the factors that go into deciding to test for oncogenic fusions, using IHC as a screening tool, and more!

We’re happy to welcome our guests Dr. James Solomon, Assistant Professor of Pathology and Laboratory Medicine at Weill Cornell Medicine and Assistant Attending Physician at the New York Presbyterian Hospital and Dr. Ashish Saxena is an Assistant Professor of Medicine at Weill Cornell Medical College and Assistant Attending Physician at the New York-Presbyterian Hospital.

Other episodes in the series are available to listen now.

Listen now!

We are excited to announce that our fifth episode is available now.

Targeted therapies in cancer: From clinic to labs

Episode 4 in the ‘Better Testing, Better Treatment’ podcast series, focuses on the topic of implementing target therapies in cancer, from a European point of view. This podcast will see a pathologist and oncologist discussing the topic from their perspectives and express similarities and differences.

Our guests include Professor. Frederique Penault-Llorca, CEO of the Comprehensive Regional Cancer Institute Centre Jean PERRIN, Clermont-Ferrand, France and Deputy President, UNICANCER, and Professor Pascal Pujol, Head of Cancer Genetics department at the University Hospital of Montpellier, France and President of the French Society of Predictive and Personalized Medicine (SFMPP).

We are excited to announce that our fourth episode is available now.

Targeted therapies in Gastric cancer: From clinic to labs

Episode 3 in the ‘Better Testing, Better Treatment’ podcast series, focuses on the topic of implementing target therapies in gastric cancer. This podcast will see a pathologist and oncologist discussing the topic from their perspectives and express similarities and differences. 

Our pathologist, Dr.Dhanpat Jain is a Professor of Pathology and Internal Medicine (section of Digestive Diseases) at Yale School of Medicine, and our oncologist, Dr. Stacey Stein, is an Associate Professor of Medicine, also at the Yale School of Medicine. 

We are excited to announce that our third episode is available now.

We are excited to announce the second episode of our podcast series, ‘Better Testing, Better Treatment’, is available!

Artificial Intelligence in Breast Cancer: from Labs to Clinic

We are fortunate to invite two experts in the field of breast cancer who share their experiences of using artificial intelligence within their laboratories.

Oncologist, Dr. Elie Rassy, and pathologist, Dr. Magali Lacroix-Triki, from the Gustave Roussy Cancer Campus, dive into discussions about the profound impact that AI has brought to breast cancer diagnosis. By listening to this podcast, you will learn about current projects utilizing artificial intelligence, the challenges that AI brings to pathology labs and the future potential of this innovative technology.

Other episodes in the series are available to listen now!

Diaceutics are proud to launch our new podcast series, 'Better Testing, Better Treatment'!

The ‘Better Testing, Better Treatment’ podcast is now available. This podcast aims to bring a clinician and a laboratory expert together to discuss the same topic from both perspectives. The first podcast covers the topic of HRD with guest speakers Professor Massimo Barberis, MD, a Pathologist at the European Institute of Clinical Oncology in Milan, Italy, and Professor Domenica Lorusso, a Gynecologist Oncologist at Hospital Policlinico Gemelli in Rome, Italy. These two experts have an intense discussion surrounding their views on HRD and its components. Listen to the full version of the podcast now! 

Insights

Artificial Intelligence in Prostate Cancer: from clinic to lab

Oncogenic Fusion detection and reporting in NSCLC and solid tumors: from clinic to lab

Targeted therapies in cancer: From clinic to labs

Targeted therapies in Gastric cancer: From clinic to labs

Artificial Intelligence in breast cancer: From clinic to lab

HRD testing: From clinic to lab